Related Experiment Video
Updated: Sep 18, 2025

Examination of Proteins Bound to Nascent DNA in Mammalian Cells Using BrdU-ChIP-Slot-Western Technique
Published on: January 14, 2016
The DNA-PKcs/JNK/p53 pathway underlies changes in cell fate decision toward death during DNA replication catastrophe
Jinal A Patel1, Julie Rageul1, Natalie Lo1
1Department of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, NY 11794, United States.
Abstract:
Exacerbating the DNA replication problems of cancer cells serves as a viable therapeutic approach. Nevertheless, the cytotoxicity of cancer drugs is often hampered by therapy-induced senescence, leading to unfavorable patient outcomes. Here, we employ acute replisome dysfunction in combination with Ataxia telangiectasia and Rad3-related (ATR) inhibition as a strategy to divert senescent cells toward death by triggering DNA replication catastrophe, a form of irreversible replication fork collapse caused by excessive single-stranded DNA (ssDNA) accumulation. RNA-sequencing revealed a distinct set of p53-responsive genes responsible for death. We identify c-Jun N-terminal kinase (JNK) to be essential for augmenting p53-dependent apoptotic programs and inducing pan-nuclear distribution of γH2AX, together constituting a feed-forward loop to drive cell death. Activation of DNA-PKcs initiates the signaling cascade of replication catastrophe, including CHK1-dependent JNK activation, which relies on MRE11 and PARP1 to expand and recognize ssDNA gaps, defining replication-associated gaps as an underlying basis for replication catastrophe. Our study elucidates the dynamic regulation of proximal and distal effectors along the DNA-PKcs/JNK/p53 axis that govern the cell fate decision between senescence and death. We propose that key determinants of replication catastrophe signaling are targetable vulnerabilities that can be exploited to limit senescent cell populations and increase the efficacy of anti-cancer therapies.
Insights
Targeting cancer cell DNA replication with ATR inhibitors can trigger replication catastrophe, a form of cell death. This strategy diverts therapy-induced senescent cells toward apoptosis, enhancing anti-cancer therapy efficacy.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Biology
Background:
- Cancer therapy often faces limitations due to therapy-induced senescence, which can negatively impact patient outcomes.
- Exacerbating DNA replication stress in cancer cells is a potential therapeutic strategy.
Purpose of the Study:
- To investigate a novel therapeutic strategy combining acute replisome dysfunction with Ataxia telangiectasia and Rad3-related (ATR) inhibition.
- To divert senescent cancer cells towards cell death by inducing replication catastrophe.
Main Methods:
- Utilized RNA-sequencing to identify p53-responsive genes involved in cell death.
- Investigated the role of c-Jun N-terminal kinase (JNK) in p53-dependent apoptosis and γH2AX distribution.
- Elucidated the signaling cascade involving DNA-PKcs, CHK1, MRE11, and PARP1 in replication catastrophe.
Main Results:
- Identified a distinct set of p53-responsive genes critical for inducing cell death.
- Demonstrated that JNK activation forms a feed-forward loop with p53 to drive apoptosis and γH2AX pan-nuclear distribution.
- Established that DNA-PKcs activation initiates replication catastrophe signaling, involving MRE11 and PARP1 in recognizing single-stranded DNA gaps.
Conclusions:
- The study elucidates the DNA-PKcs/JNK/p53 signaling axis regulating cell fate decisions between senescence and death.
- Replication catastrophe, driven by specific signaling pathways, represents a targetable vulnerability in cancer therapy.
- This approach holds potential for limiting senescent cell populations and improving anti-cancer treatment efficacy.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
The Intrinsic Apoptotic Pathway
S-Cdk Initiates DNA Replication
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
Inhibition of Cdk Activity
Abnormal Proliferation

